All products / Type / Easy Pen
Semaglutide 10mg - Easy Pen
Powerful Support for Weight Loss, Blood Sugar Balance, and Inflammation Reduction
SKU: EP-SEM-10-1
99% PurityTHB 5,100THB 4,080Save THB 1,020 (−20%)
- Format
- Easy Pen
- Dosage
- 0.05mg Per Click / Up to 60 clicks per dose.
- Capacity
- 10mg
Potential benefits
- Sustainable Weight Loss
- Improved Blood Sugar Regulation
- Reduced Visceral Fat
- Liver Health & Fat Reduction
- Cardiovascular Protection
- Supports Gut-Brain Signaling
- Anti-Inflammatory Effects
- Neuroprotective Potential
Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) originally developed for type 2 diabetes, now widely used for its powerful metabolic effects including significant weight loss, appetite regulation, improved insulin sensitivity, and reduction in systemic inflammation. By mimicking the body’s natural GLP-1 hormone, semaglutide not only controls blood glucose levels but also promotes satiety and supports healthier long-term body composition.
Semaglutide is purported to work by mimicking the GLP-1 hormone, which is naturally released in response to food. It binds to GLP-1 receptors found in the pancreas, gut, brain, and other tissues, producing a cascade of potential beneficial metabolic effects. This peptide therapy may benefit both individuals with metabolic conditions and those seeking medically supported weight management.
Semaglutide is purported to work by mimicking the GLP-1 hormone, which is naturally released in response to food. It binds to GLP-1 receptors found in the pancreas, gut, brain, and other tissues, producing a cascade of potential beneficial metabolic effects. This peptide therapy may benefit both individuals with metabolic conditions and those seeking medically supported weight management.
- Reduces appetite and caloric intake by enhancing satiety and delaying gastric emptying. Clinical trials show average body weight reductions of 10–15%, with some exceeding 20% after consistent use.
- Increases insulin secretion and decreases glucagon production in a glucose-dependent manner, helping to stabilize blood sugar levels and reduce HbA1c.
- Targets abdominal fat more effectively than diet and exercise alone, improving body composition and reducing metabolic risk.
- Shown to reduce hepatic fat accumulation, supporting improvement in non-alcoholic fatty liver disease (NAFLD/MASLD).
- Lowers blood pressure, LDL cholesterol, triglycerides, and inflammation, offering protective effects against heart disease.
- Acts on the brain's appetite centers, reducing hunger and compulsive eating behaviors without triggering cravings or emotional eating rebounds.
- Decreases systemic inflammation markers such as CRP and IL-6, which may contribute to improvements in energy, immunity, and metabolic resilience.
- Early studies suggest support for cognitive health, including reduced neuroinflammation and protection against brain cell damage in obese or insulin-resistant individuals.
References
- https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- https://www.nejm.org/doi/full/10.1056/NEJMoa2413258
- https://www.nature.com/articles/s41591-024-03018-2
- https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
- https://www.sciencedaily.com/releases/2025/05/250527124029.htm
- https://peerj.com/articles/17891/
- https://www.mdpi.com/1422-0067/25/9/4972
| Molecular formula | C187H291N45O59 |
|---|---|
| Molecular weight | 4113.6 Da |
| CAS number | 910463-68-2 |
| Purity | 99% |
| Storage | Use within 30 days of first use. Store at 2–8°C / 35–46°F. Protect from sunlight. Do not freeze. |
Sequence: His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18-diacid-gamma-Glu-OEG-OEG)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly
Synonyms: Semaglutide, Rybelsus, Ozempic, 910463-68-2, Wegovy